SCHEMBL18800716

SCHEMBL18800716

Cc1cc(-c2cncc(N)c2C(=N)N)ccc1Oc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCQ Q04759 1/20 0.37
▸ F2 P00734 1/20 0.36
▸ PLG P00747 1/20 0.36
▸ PRSS1 P07477 1/20 0.36
▸ TNK2 Q07912 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ BTK Q06187 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ BRD4 O60885 3/20 0.34
▸ ICAM1 P05362 1/20 0.34
▸ SELE P16581 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ S1PR1 P21453 1/20 0.33
▸ S1PR3 Q99500 1/20 0.33
▸ STK39 Q9UEW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800614 0.86 ERBB2 (0.42) PRKCQTNK2CYP1A2CYP2C9CYP2C19
SCHEMBL18800598 0.76 KDM4E (0.51) F2PLGPRSS1CYP1A2CYP2C9
SCHEMBL18800626 0.76 SMN1; SMN2 (0.48) F2PRSS1CYP1A2CYP2C9CYP2C19
SCHEMBL18800738 0.76 TDO2 (0.49) PRSS1CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL18800606 0.74 NQO2 (0.43) F2PRSS1CYP1A2CYP2C9CYP2C19
SCHEMBL18800610 0.73 BTK (0.43) F2PRSS1ALDH1A1BTKCYP3A4
SCHEMBL18800739 0.73 MEN1 (0.39) F2PRSS1BTK
SCHEMBL18800557 0.72 PRSS1 (0.45) PRSS1CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL6116428 0.72 BTK (0.54) BTK
SCHEMBL18800867 0.69 BTK (0.50) PRSS1CYP1A2CYP2C19BTKGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback